436 related articles for article (PubMed ID: 18685562)
1. Using publicly available information to create exposure and risk-based ranking of chemicals used in the workplace and consumer products.
Jayjock MA; Chaisson CF; Franklin CA; Arnold S; Price PS
J Expo Sci Environ Epidemiol; 2009 Jul; 19(5):515-24. PubMed ID: 18685562
[TBL] [Abstract][Full Text] [Related]
2. Priority setting for risk assessment--the benefit of human experience.
Alonzo C; Laborde A
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):692-6. PubMed ID: 16153990
[TBL] [Abstract][Full Text] [Related]
3. Assessments of direct human exposure: the approach of EU risk assessments compared to scenario-based risk assessment.
Wormuth M; Demou E; Scheringer M; Hungerbühler K
Risk Anal; 2007 Aug; 27(4):979-90. PubMed ID: 17958505
[TBL] [Abstract][Full Text] [Related]
4. Toxicological comments to the discussion about REACH.
Greim H; Arand M; Autrup H; Bolt HM; Bridges J; Dybing E; Glomot R; Foa V; Schulte-Hermann R
Arch Toxicol; 2006 Mar; 80(3):121-4. PubMed ID: 16411136
[TBL] [Abstract][Full Text] [Related]
5. Tools for the prioritization of substances on the Domestic Substances List in Canada on the basis of hazard.
Hughes K; Paterson J; Meek ME
Regul Toxicol Pharmacol; 2009 Dec; 55(3):382-93. PubMed ID: 19766685
[TBL] [Abstract][Full Text] [Related]
6. [Carcinogenic risk assessment of chemicals].
Hayashi Y
Eisei Shikenjo Hokoku; 1990; (108):1-16. PubMed ID: 1364333
[TBL] [Abstract][Full Text] [Related]
7. Modeling exposure to persistent chemicals in hazard and risk assessment.
Cowan-Ellsberry CE; McLachlan MS; Arnot JA; Macleod M; McKone TE; Wania F
Integr Environ Assess Manag; 2009 Oct; 5(4):662-79. PubMed ID: 19552503
[TBL] [Abstract][Full Text] [Related]
8. Default values for assessment of potential dermal exposure of the hands to industrial chemicals in the scope of regulatory risk assessments.
Marquart H; Warren ND; Laitinen J; van Hemmen JJ
Ann Occup Hyg; 2006 Jul; 50(5):469-89. PubMed ID: 16540540
[TBL] [Abstract][Full Text] [Related]
9. Stoffenmanager exposure model: development of a quantitative algorithm.
Tielemans E; Noy D; Schinkel J; Heussen H; Van Der Schaaf D; West J; Fransman W
Ann Occup Hyg; 2008 Aug; 52(6):443-54. PubMed ID: 18621742
[TBL] [Abstract][Full Text] [Related]
10. Balancing risks.
Kasamatsu T; Kohda K
Regul Toxicol Pharmacol; 2006 Oct; 46(1):100-4. PubMed ID: 16843577
[TBL] [Abstract][Full Text] [Related]
11. Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH.
Boogaard PJ; Aylward LL; Hays SM
Int J Hyg Environ Health; 2012 Feb; 215(2):238-41. PubMed ID: 22177527
[TBL] [Abstract][Full Text] [Related]
12. The exposure data landscape for manufactured chemicals.
Egeghy PP; Judson R; Gangwal S; Mosher S; Smith D; Vail J; Cohen Hubal EA
Sci Total Environ; 2012 Jan; 414():159-66. PubMed ID: 22104386
[TBL] [Abstract][Full Text] [Related]
13. [The concept of risk and its estimation].
Zocchetti C; Della Foglia M; Colombi A
Med Lav; 1996; 87(4):330-47. PubMed ID: 9102559
[TBL] [Abstract][Full Text] [Related]
14. Issues in consumer exposure modeling: towards harmonization on a global scale.
Kephalopoulos S; Bruinen de Bruin Y; Arvanitis A; Hakkinen P; Jantunen M
J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S90-100. PubMed ID: 17668010
[TBL] [Abstract][Full Text] [Related]
15. Uncertainty evaluation of human risk analysis (HRA) of chemicals by multiple exposure routes.
Sassi G; Ruggeri B
Risk Anal; 2008 Oct; 28(5):1343-56. PubMed ID: 18684163
[TBL] [Abstract][Full Text] [Related]
16. Consumer exposure scenarios: development, challenges and possible solutions.
Van Engelen JG; Heinemeyer G; Rodriguez C
J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S26-33. PubMed ID: 17505503
[TBL] [Abstract][Full Text] [Related]
17. Quantitative interpretation of human biomonitoring data.
Clewell HJ; Tan YM; Campbell JL; Andersen ME
Toxicol Appl Pharmacol; 2008 Aug; 231(1):122-33. PubMed ID: 18589468
[TBL] [Abstract][Full Text] [Related]
18. Integrating process safety with molecular modeling-based risk assessment of chemicals within the REACH regulatory framework: benefits and future challenges.
Lewis A; Kazantzis N; Fishtik I; Wilcox J
J Hazard Mater; 2007 Apr; 142(3):592-602. PubMed ID: 16930827
[TBL] [Abstract][Full Text] [Related]
19. In vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration: summary and evaluation of USEPA's mandated testing.
Fasano WJ; McDougal JN
Regul Toxicol Pharmacol; 2008 Jul; 51(2):181-94. PubMed ID: 18501488
[TBL] [Abstract][Full Text] [Related]
20. A weight-of-evidence approach for assessing interactions in chemical mixtures.
Mumtaz MM; Durkin PR
Toxicol Ind Health; 1992; 8(6):377-406. PubMed ID: 7570620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
